Impaired cough suppression in chronic refractory cough.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
05 2019
Historique:
received: 19 11 2018
accepted: 18 02 2019
pubmed: 2 3 2019
medline: 29 10 2020
entrez: 2 3 2019
Statut: epublish

Résumé

Functional brain imaging in individuals with chronic cough demonstrates reduced activation in cortical regions associated with voluntary cough suppression. Little is known about the ability of patients with chronic cough to suppress cough. This study aimed to compare the ability to voluntarily suppress cough during inhaled capsaicin challenge in participants with chronic refractory cough with that in healthy controls. In addition, this study aimed to assess the repeatability of capsaicin challenge test with voluntary cough suppression.Participants with chronic refractory cough and healthy controls underwent inhaled capsaicin challenge tests while attempting to suppress their cough responses. After 5 days, either a conventional capsaicin challenge test with no cough suppression attempt, or a repeat test with an attempt at cough suppression was performed. Threshold capsaicin concentrations required to elicit one, two and five coughs were calculated by interpolation. Objective 24-h cough frequency was measured in individuals with chronic refractory cough.Healthy controls were able to suppress capsaicin-evoked cough while participants with chronic refractory cough were not. Geometric mean±sd capsaicin dose thresholds for five coughs with (CS5) and without (C5) suppression attempts were 254.40±3.78

Identifiants

pubmed: 30819813
pii: 13993003.02203-2018
doi: 10.1183/13993003.02203-2018
pii:
doi:

Substances chimiques

Antitussive Agents 0
Capsaicin S07O44R1ZM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright ©ERS 2019.

Déclaration de conflit d'intérêts

Conflict of interest: P.S.P. Cho reports a grant from Merck outside the submitted work. Conflict of interest: H.V. Fletcher has nothing to disclose. Conflict of interest: R.D. Turner has nothing to disclose. Conflict of interest: C.J. Jolley has nothing to disclose. Conflict of interest: S.S. Birring reports grants and personal fees for advisory board work from Merck, personal fees for advisory board work from Bayer, GSK, Menlo and Sanofi, and conference travel expenses from Boehringer Ingelheim, outside the submitted work.

Auteurs

Peter S P Cho (PSP)

Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.

Hannah V Fletcher (HV)

Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.

Richard D Turner (RD)

Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.
Dept of Respiratory Medicine, Charing Cross Hospital, Imperial College Healthcare Trust, London, UK.

Caroline J Jolley (CJ)

Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.

Surinder S Birring (SS)

Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.
Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH